Börschel et al., 2015 demonstrated that an antibody-cytokine fusion protein L19-IL2 that specifically delivers IL-2 to the tumor site by homing to the extra-domain B of fibronectin led to significant lymphoma growth retardation. The gene discussed is IL2; the disease is neoplasm.